Physiologic changes incurred by pregnancy can cause severe decompensation in the parturient with underlying cardiac disease. The result is increased morbidity and mortality for both mother and child. Appropriate anesthetic management can significantly impact these outcomes. This review systematically presents the pathophysiology, peripartum risk, and anesthetic management in the puerperium of specific acquired cardiac abnormalities including: valvular disease, pulmonary hypertension, cardiomyopathy, cardiac transplantation, ischemia, arrhythmias, and cardiac arrest.
KuklinaECallaghanW. Chronic heart disease and severe obstetric morbidity among hospitalizations for pregnancy in the USA: 1995–2006. BJOG2011;118:345–352.
2.
KleinLLGalanHL. Cardiac disease in pregnancy. Obstet Gynecol Clin North Am2004;31:429–59, viii.
GaiserR. Physiologic Changes of Pregnancy. In ChestnutDHPolleyLSTsenLCWongCA, eds. Chestnut’s Obstetric Anesthesia: Principles and Practice, 4th ed.Philadelphia. Mosby Elsevier2009; 15-36.
8.
SuiSCSermerMColmanJMAlvarezANMercierLAMortonBC. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation2001;104:515-521.
9.
SiuSCColmanJMSorensenSSmallhornJFFarineDAmankwahKS. Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation2002;105:2179–84.
10.
AyoubCMJalboutMIBarakaAS. The pregnant cardiac woman. Current Opinion in Anaesthesiology2002;15:285-291.
11.
BonowROCarabelloBAChatterjeeKde LeonACJrFaxonDPFreedMD. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary. (Writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease). Circulation2006;114:84-231.
12.
HameedAKaraalpISTummalaPPWaniORCanettiMAkhterMW. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol2001;37(3):893– 9.
13.
HemmingsGTWhalleyDGO’ConnorPJBenjaminADunnC. Invasive monitoring and anesthetic management of a parturient with mitral stenosis. Can J Anaesth1987;34: 182-185.
14.
OttoCMBonowRO. Valvular Heart Disease. In: BonowROMannDLZipesDPLibbyPBraunwaldE, eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 9th ed.Boston. Elsevier Saunders2011; 1468-1539.
15.
KochCG. Mitral Valve Stenosis. In: PerrinoACJrReevesST, eds. A Practical Approach to Transesophageal Echocardiography, 2nd ed.Philadelphia. Lippincott Williams & Wilkins; 2008; 189-204.
16.
PanPD’AngeloR. Anesthetic and analgesic management of mitral stenosis during pregnancy. Reg Anesth Pain Med. 2004;29:610-615.
17.
WalshWF. Medical Management of Chronic Rheumatic Heart Disease. Heart, Lung and Circulation. 2010;19:289–294.
18.
CohenIS. Aortic Stenosis. In: PerrinoACJrReevesST, eds. A Practical Approach to Transesophageal Echocardiography, 2nd ed. Philadelphia. Lippincott Williams & Wilkins; 2008; 241-256.
19.
KuczkowskiKMvan ZundertA. Anesthesia for pregnant women with valvular heart disease the state-of-the-art.J Anesth2007;21:252–257.
20.
ElkayamUBitarF. Valvular Heart Disease and Pregnancy Part I: Native Valves.J Am Coll Cardiol2005;46:223–30.
21.
LambertAS. Mitral Regurgitation. In: PerrinoACJrReevesST, eds. A Practical Approach to Transesophageal Echocardiography, 2nd ed.Philadelphia. Lippincott Williams & Wilkins;2008; 171-188.
22.
RamseyPSRaminKDRaminSM. Cardiac disease in pregnancy. American Journal of Perinatology. 2001;18:245-265.
23.
CohenIS. Aortic Regurgitation. In: PerrinoACJrReevesST, eds. A Practical Approach to Transesophageal Echocardiography, 2nd ed.Philadelphia. Lippincott Williams & Wilkins; 2008; 226-240.
24.
SimonneauGGalieNRubinLJLanglebenDSeegerWDomenighettiG; Updated Clinical Classification of Pulmonary Hypertension; J Am Coll Cardiol2009;54:S43–54.
25.
ToshnerMTajsicTMorrellNW. Pulmonary hypertension: advances in pathogenesis and treatment. British Medical Bulletin2010; 94: 21–32
26.
RayPMurphyGJShuttLE. Recognition and management of maternal cardiac disease in pregnancy. British Journal of Anaesthesia2004;93:428-439.
27.
WeissBMZempLSeifertBHessOM. Outcome of Pulmonary Vascular Disease in Pregnancy: A Systematic Overview From 1978 Through 1996. J Am Coll Cardiol1998;31:1650–7.
28.
MaddenBP. Pulmonary hypertension and pregnancy. Int J Obstet Anes2009; 18: 156–164.
29.
SliwaKHilfiker-KleinerDPetrieMCMebazaaAPieskeBBuchmannE. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail2010; 12:767–778.
30.
PearsonGDVeilleJCRahimtoolaSHsiaJOakleyCMHosenpudJD. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases recommendations and review. JAMA2000;283:1183-1188.
31.
GarwoodS. Left Ventricular Systolic Performance and Pathology. In: PerrinoACJrReevesST, eds. A Practical Approach to Transesophageal Echocardiography, 2nd ed.Philadelphia. Lippincott Williams & Wilkins; 2008; 53-86.
32.
MaronBJMcKennaWJDanielsonaGKKappenbergeraLJKuhnbHJSeidmanCE. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. European Heart Journal (2003) 24, 1965–1991.
Van Spaendonck-ZwartsKYVan TintelenJPVan VeldhuisenDJVan der WerfRJongbloedJDHPaulusWJ. Peripartum Cardiomyopathy as a Part of Familial Dilated Cardiomyopathy. Circulation. 2010;121:2169-2175.
35.
McKayDBJosephsonMA. Reproduction and Transplantation: Report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant2005; 5: 1592–1599.
36.
McKayDBJosephsonMA. Pregnancy in Recipients of Solid Organs ― Effects on Mother and Child. N Engl J Med2006;354:1281-93.
37.
BlascoLMParameshwarbJVuylstekeA. Anaesthesia for noncardiac surgery in the heart transplant recipient. Current Opinion in Anaesthesiology2009; 22:109–113.
38.
LadnerHEDanielsenBGilbertWM. Acute Myocardial Infarction in Pregnancy and the Puerperium: A Population-Based Study. Obstet Gynecol2005;105:480–4.
39.
MartinSRFoleyMR. Intensive care in obstetrics: An evidence-based review. Am J Obstet Gyn2006; 195:673–89.
40.
GowdaRMKhanIAMehtaNJVasavadaBCSacchiTJ. Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations. Int J Cardiol2003;88:129–133.
41.
TrappeHJ. Acute Therapy of Maternal and Fetal Arrhythmias During Pregnancy. Intensive Care Med2006;21:305-15.
42.
BarthWHJr. Cardiac Surgery in Pregnancy. Clin Obstet Gyn2009; 52:630–646.
43.
ECC Committee, Subcommittees and Task Forces of the American Heart Association. 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: Part 10.8: Cardiac Arrest Associated With Pregnancy. Circulation2005;112 [Suppl I]:IV-150-IV-153
44.
WilliamsonRMHainesJ. Availability of lipid emulsion in obstetric anaesthesia in the UK: a national questionnaire survey. Anaesthesia2008; 63:385–388.
45.
ToledoP. The role of lipid emulsion during advanced cardiac life support for local anesthetic toxicity. Int J Obstet Anesth2011; 20:60–63.
46.
WeinbergGL. Treatment of Local Anesthetic Systemic Toxicity (LAST). Reg Anesth Pain Med2010;35:188-193.
47.
ClarkSLPhelanJPGreenspoonJAldahlDHorensteinJ. Labor and delivery in presence of mitral stenosis: Central hemodynamic observations. Am J Obstet Gynecology1985;152:984-988.
